Cambridge, Bulgaria

Atanas Yordanov Georgiev

This inventor holds 1 USPTO granted patent. Top assignee: Nuclera Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atanas Yordanov Georgiev. Retrieved from https://idiyas.com/inventor/atanas-yordanov-georgiev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Atanas Yordanov Georgiev: Innovator in Protein Synthesis Monitoring

Introduction

Atanas Yordanov Georgiev is a notable inventor based in Cambridge, Bulgaria. He has made significant contributions to the field of protein synthesis, showcasing his expertise through innovative research and development.

Latest Patents

Georgiev holds a patent for "Monitoring of In Vitro Protein Synthesis." This patent reflects his commitment to advancing scientific knowledge and technology in the area of protein synthesis.

Career Highlights

Currently, Atanas Yordanov Georgiev is associated with Nuclera Ltd., where he applies his skills and knowledge to further the company's mission. His work at Nuclera Ltd. emphasizes the importance of innovation in biotechnology.

Collaborations

Georgiev collaborates with talented individuals such as Chiara Gandini and Stephanie Reikine. These partnerships enhance the research environment and contribute to the success of their projects.

Conclusion

Atanas Yordanov Georgiev is a dedicated inventor whose work in protein synthesis monitoring exemplifies the spirit of innovation. His contributions to the field are invaluable and continue to inspire future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…